Canadian life sciences company MDS has reported preliminary results for the fourth quarter showing that net revenues at its US-based contract research unit, MDS Pharma Services, dropped by 8.9% year on year to US$112 million.
Read MoreNew funding from Vodafone Ventures Ltd will enable t+ Medical, the UK-based company that supplies mobile phone-based technology for capturing patient data in long-term condition management and clinical trials, to accelerate the roll-out of its mPRO (mobile patient reported outcomes) platform.
Read MoreClinical trials of new drugs and biologics for type 2 diabetes should put more emphasis on showing that the therapies do not increase the risk of cardiovascular events such as heart attacks, the US Food and Drug Administration has recommended.
Read MoreUS-based contract research organisation (CRO) PPD has announced plans for new laboratory services in Singapore and Ireland that will come onstream during 2009.
Read MorePharmaNet Development Group, the US-based contract research organisation (CRO) hit hard by a spate of project cancellations in its crucial late-stage business, says it is working with its financial adviser “to pursue strategic alternatives, including the potential sale of the Company and the exploration of alternatives to retire the Company’s convertible notes”.
Read More
